Sep 26, 2023 / 02:30PM GMT
Charles Duncan - Cantor Fitzgerald & Co. - Analyst
I think we should get started on the next presenting panel. So I'm Charles, I'm a senior biotech analyst with Cantor, and it's a pleasure to introduce the next presenting panel that is comprised of two folks who I've known for quite some time. They're doing some pretty innovative work in neurodegenerative diseases. Both of them with a broad platform that is focused on inflammation.
So why conduct this panel? Well, because I think for neurodegenerative diseases, neurology, even psychiatry, inflammation is important and is perhaps one of the components of etiology that really drives disease progression. So it's a pleasure to introduce Mr. Mark Litton, the CEO -- President and CEO of Athira Pharma. Mark, nice to see you. Thanks for joining.
Mark Litton - Athira Pharma Inc - President&CEO
Hello.
Charles Duncan - Cantor Fitzgerald & Co. - Analyst
And Mr. Cuong Do, the President and CEO of BioVie. Cuong, great to have you. Thanks for joining.
Athira Pharma Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers